Home
/
Hormone

Measuring Testosterone / ApoB: Hormone Status Meets Particle Load

REVIEWED BY
William Maish, MD MBA MPH
Clinical Product Lead
Published
November 15, 2025
Last updated
June 4, 2026
Quick answer:

This test pairs testosterone—the primary androgen driving libido, muscle, bone, and energy—with ApoB, which counts atherogenic LDL-type particles that build arterial plaque. Testosterone is associated with vitality and metabolic health, while lower ApoB reflects fewer artery-damaging lipoproteins; together they frame hormonal status and cardiovascular risk, interpreted alongside SHBG, free testosterone, and metabolic markers like A1c.

Read more →
Table of contents

Testosterone and ApoB together: Hormone status meets atherogenic particle load

Testosterone / ApoB blood testing measures two distinct molecules with big biological roles: testosterone, a steroid hormone, and apolipoprotein B (ApoB), a structural protein on cholesterol-carrying particles. Testosterone is made mainly in the testes, with smaller amounts from the ovaries and adrenal glands. ApoB is produced in the liver (ApoB‑100) and intestine (ApoB‑48) and is built into the surface of lipoproteins that move fats through the bloodstream—especially VLDL and LDL, often called “bad cholesterol.”

Testosterone drives reproductive function, sexual development, muscle and bone maintenance, red blood cell production, energy, and libido (androgen/sex‑steroid signaling). ApoB acts as the required “address tag” that lets fat-rich particles be assembled, released, and taken up by tissues; because each LDL-type particle carries one ApoB molecule, the ApoB level reflects the number of artery-entering particles in circulation (atherogenic lipoprotein particle burden). Together, these measurements capture two fundamentals: hormonal status that shapes body composition and vitality, and lipid transport that influences how fats are delivered to—and can accumulate within—artery walls.

Why looking at testosterone alongside ApoB clarifies cardiometabolic risk in men

This combined test looks at two core axes of health: testosterone, the body’s primary anabolic sex hormone, and apolipoprotein B (ApoB), the protein “tag” on LDL and related particles that deliver cholesterol and can seed plaque. Together they link energy, strength, and reproductive signaling with the number of artery‑entering particles that drive atherosclerosis.

Big picture: testosterone shapes body composition, mood, and metabolic rate, which in turn influence lipids; ApoB quantifies the particles that actually deliver cholesterol into artery walls. Together they frame vitality and long‑term cardiovascular risk.

Low, mid, and high pairings — what the testosterone/ApoB picture suggests

In adults, total testosterone is much higher in men than women, peaks in late teens/20s, and falls with age; people tend to feel best when values sit in the mid range for their age and sex. ApoB varies less by sex and is considered more favorable toward the low end of its reference interval because fewer atherogenic particles means lower plaque exposure.

When testosterone runs low, physiology shifts toward reduced protein synthesis and lower dopamine/androgen signaling: fatigue, low libido, depressed mood, reduced muscle and bone, and sometimes anemia. In women, very low values can blunt sexual desire and vitality; in teens it may impair pubertal progression. Very low ApoB usually reflects few LDL particles and lower vascular risk; if extreme, it can signal malabsorption or rare genetic hypobetalipoproteinemia.

When testosterone runs high, men may see acne, oily skin, irritability, and elevated red blood cells; women can develop hirsutism, acne, and irregular periods (often with ovarian androgen excess). High ApoB indicates many LDL/VLDL particles, a strong driver of plaque formation, especially with insulin resistance or diabetes.

Caveats that nudge testosterone or ApoB outside of underlying biology

Notes: Testosterone peaks in the morning; total versus free depends on sex hormone–binding globulin (SHBG), influenced by age, thyroid status, estrogens, and liver disease. LC–MS assays are more accurate at low testosterone than immunoassays. ApoB is relatively fasting-independent; lipoprotein(a) is included within ApoB. Pregnancy and acute illness alter both.

Where the testosterone/ApoB pair fits in a longevity-focused panel

This paired test assesses testosterone, the chief androgen, and ApoB, the number of atherogenic lipoprotein particles. Together they link anabolic signaling and lipid transport to energy, body composition, fertility, cognition, and cardiovascular risk.

Low values usually reflect reduced androgen effect or fewer atherogenic particles. Low testosterone in men indicates underproduction or high binding (low free fraction), with lower energy, libido, muscle, and bone; in women, dampened desire and bone accrual. Low ApoB means fewer plaque-forming particles; very low may reflect impaired lipoprotein production or malabsorption/liver disease. With age testosterone declines; pregnancy lowers free testosterone and tends to raise ApoB.

Being in range suggests age-appropriate androgen signaling and an ApoB particle burden compatible with healthy lipid transport. For ApoB, lower within normal is generally favored for vascular protection. For testosterone, mid-range for age/sex often aligns with stable physiology.

High values usually reflect increased production/exposure or impaired clearance. High testosterone from exogenous androgens or low binding proteins can drive acne and elevated red cells in males, and hirsutism, acne, and irregular cycles in females (hyperandrogenism/PCOS). High ApoB denotes many atherogenic particles from overproduction or slow clearance and higher plaque risk.

FAQs

  • It measures blood levels of testosterone and apolipoprotein B (ApoB) to assess androgen status and atherogenic particle number—two drivers of performance and cardiovascular risk.
  • Testosterone testing clarifies contributors to energy, libido, muscle and bone maintenance, body composition, mood, and training response, and helps you monitor changes over time.
  • Frequency depends on your goals, age, baseline results, and whether you are making lifestyle or therapy changes. Consistent intervals make trends easier to interpret.
  • Diet, exercise, sleep, stress, body fat, illness, and certain medications can change testosterone levels, as can aging and training load.
  • Some tests may require specific preparations such as fasting. Follow the instructions provided with your test to helps support accurate measurement.

    Superpower currently offers at-home blood testing in the following states: Alabama, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Kansas, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, and Wisconsin.

    We’re actively expanding nationwide, with new states being added regularly. If your state isn’t listed yet, stay tuned.

    References

    1. Chen, Z., Zhang, E., Gan, L., Jiang, G., Duan, Q., Huang, M., Li, H., & Huang, G. (2024). Analysis of the association between testosterone and cardiovascular disease potential risk factor apolipoprotein B in adult males without cancer: National Health and Nutrition Examination Survey 2011-2016. Frontiers in Endocrinology, 15, 1304344. https://doi.org/10.3389/fendo.2024.1304344
    2. Sniderman, A. D., Williams, K., Contois, J. H., Monroe, H. M., McQueen, M. J., de Graaf, J., & Furberg, C. D. (2011). A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk. Circulation: Cardiovascular Quality and Outcomes, 4(3), 337-345. https://doi.org/10.1161/CIRCOUTCOMES.110.959247
    3. Feingold, K. R. (2024). Introduction to lipids and lipoproteins. In Endotext. MDText.com, Inc. https://www.ncbi.nlm.nih.gov/books/NBK305896/
    4. Ference, B. A., Ginsberg, H. N., Graham, I., Ray, K. K., Packard, C. J., Bruckert, E., Hegele, R. A., Krauss, R. M., Raal, F. J., Schunkert, H., Watts, G. F., Borén, J., Fazio, S., Horton, J. D., Masana, L., Nicholls, S. J., Nordestgaard, B. G., van de Sluis, B., Taskinen, M. R., ... Catapano, A. L. (2017). Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. European Heart Journal, 38(32), 2459-2472. https://doi.org/10.1093/eurheartj/ehx144
    5. Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., Graham, I. M., Halliday, A., Landmesser, U., Mihaylova, B., Pedersen, T. R., Riccardi, G., Richter, D. J., Sabatine, M. S., Taskinen, M. R., ... Wiklund, O. (2020). 2019 ESC/EAS guidelines for the management of dyslipidaemias. European Heart Journal, 41(1), 111-188. https://doi.org/10.1093/eurheartj/ehz455

    Built by the world’s top doctors and scientists

    Dr Anant Vinjamoori, MD

    Chief Longevity Officer, Superpower

    Board-certified longevity physician. Previously product leader at Virta Health & CMO at Modern Age. Featured in  WSJ, Forbes, and Fortune.

    Learn more

    Dr Leigh Erin Connealy, MD

    Clinician & Founder of The Centre for New Medicine

    Leads the largest integrative medical clinic in North America. A pioneer in integrative oncology.

    Learn more

    Dr Robert Lufkin

    UCLA Medical Professor, NYT Bestselling Author

    A leading voice on metabolic health and longevity as shown in The Today Show, USA Today and FOX.

    Learn more

    Dr Abe Malkin

    Founder & Medical Director of Concierge MD

    Leads a nationwide medical practice, and Drip Hydration, a mobile IV therapeutics company

    Learn more
    Membership slide 1
    Membership slide 1
    Membership slide 2
    Membership slide 3
    1 / 3

    Your membership starts here

    Annual 100+ biomarker panel

    Data dashboard and digital twin

    Upload past labs and connect wearables

    Personalized health protocol

    24/7 care team access

    AI companion for all health questions

    Marketplace with additional solutions

    $199

    /year*

    Billed annually

    HSA/ FSA eligible
    Cancel anytime
    Results in a week

    * Pricing may vary for members in New York and New Jersey